메뉴 건너뛰기




Volumn 14, Issue 4, 2015, Pages 593-599

The use of insulin detemir during pregnancy: A safety evaluation

Author keywords

Detemir; Diabetes mellitus; Gestational; Pregnancy; Safety

Indexed keywords

HUMAN INSULIN; INSULIN DETEMIR; ISOPHANE INSULIN; ANTIDIABETIC AGENT;

EID: 84924993737     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2015.1013533     Document Type: Article
Times cited : (15)

References (74)
  • 1
    • 43249096940 scopus 로고    scopus 로고
    • Hyperglycemia and adverse pregnancy outcomes
    • Group HSCR.Metzger BE, Lowe LP, et al.Hyperglycemia and adverse pregnancy outcomes.N Engl J Med 2008; 358(19): 1991-2002
    • (2008) N Engl J Med , vol.358 , Issue.19 , pp. 1991-2002
    • Group, H.1    Metzger, B.E.2    Lowe, L.P.3
  • 2
    • 61349099439 scopus 로고    scopus 로고
    • American Diabetes Association Diabetes Care
    • American Diabetes Association.Diagnosis and classification of diabetes mellitus.Diabetes Care 2009; 32(Suppl 1): S62-7
    • (2009) Diagnosis and Classification of Diabetes Mellitus , vol.32 , pp. S62-S67
  • 3
    • 48649086952 scopus 로고    scopus 로고
    • Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/.ethnically diverse population of pregnant women, 1999-2005
    • Lawrence JM, Contreras R, Chen W, et al.Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/.ethnically diverse population of pregnant women, 1999-2005.Diabetes care 2008; 31(5): 899-904
    • (2008) Diabetes Care , vol.31 , Issue.5 , pp. 899-904
    • Lawrence, J.M.1    Contreras, R.2    Chen, W.3
  • 4
    • 84896530189 scopus 로고    scopus 로고
    • Force uspst.screening for gestational diabetes mellitus: Us preventive services task force recommendation statement
    • Moyer VA; Force USPST.Screening for gestational diabetes mellitus: U.S.preventive services task force recommendation statement.Ann Intern Med 2014; 160(6): 414-20
    • (2014) Ann Intern Med , vol.160 , Issue.6 , pp. 414-420
    • Moyer, V.A.1
  • 6
    • 34447127396 scopus 로고    scopus 로고
    • Increasing prevalence of gestational diabetes mellitus: A public health perspective
    • Ferrara A.Increasing prevalence of gestational diabetes mellitus: a public health perspective.Diabetes Care 2007; 30(Suppl 2): S141-6
    • (2007) Diabetes Care , vol.30 , pp. S141-S146
    • Ferrara, A.1
  • 7
    • 0029939133 scopus 로고    scopus 로고
    • Is macrosomia associated with poor glycaemic control in diabetic pregnancy?
    • Page RC, Kirk BA, Fay T, et al.Is macrosomia associated with poor glycaemic control in diabetic pregnancy?.Diabet Med 1996; 13(2): 170-4
    • (1996) Diabet Med , vol.13 , Issue.2 , pp. 170-174
    • Page, R.C.1    Kirk, B.A.2    Fay, T.3
  • 8
    • 0032878096 scopus 로고    scopus 로고
    • Spontaneous abortions and major malformations in women with diabetes mellitus
    • Greene MF.Spontaneous abortions and major malformations in women with diabetes mellitus.Semin Reprod Endocrinol 1999; 17(2): 127-36
    • (1999) Semin Reprod Endocrinol , vol.17 , Issue.2 , pp. 127-136
    • Greene, M.F.1
  • 9
    • 0034522103 scopus 로고    scopus 로고
    • Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies the national institute of child health and human development maternal- fetal medicine units network
    • Sibai BM, Caritis SN, Hauth JC, et al.Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies.The national institute of child health and human development maternal- fetal medicine units network.Am J Obstet Gynecol 2000; 183(6): 1520-4
    • (2000) Am J Obstet Gynecol , vol.183 , Issue.6 , pp. 1520-1524
    • Sibai, B.M.1    Caritis, S.N.2    Hauth, J.C.3
  • 10
    • 0034107268 scopus 로고    scopus 로고
    • A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels
    • McElvy SS, Miodovnik M, Rosenn B, et al A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels.J Matern Fetal Med 2000; 9(1): 14-20
    • (2000) J Matern Fetal Med , vol.9 , Issue.1 , pp. 14-20
    • McElvy, S.S.1    Miodovnik, M.2    Rosenn, B.3
  • 11
    • 1942446311 scopus 로고    scopus 로고
    • Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the netherlands
    • Evers IM, de Valk HW, Visser GH.Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands.BMJ 2004; 328(7445): 915
    • (2004) BMJ , vol.328 , Issue.7445 , pp. 915
    • Evers, I.M.1    De Valk, H.W.2    Visser, G.H.3
  • 12
    • 21444454435 scopus 로고    scopus 로고
    • Type 2 diabetes and pregnancy
    • Dunne F.Type 2 diabetes and pregnancy.Semin Fetal Neonatal Med 2005; 10(4): 333-9
    • (2005) Semin Fetal Neonatal Med , vol.10 , Issue.4 , pp. 333-339
    • Dunne, F.1
  • 13
    • 9444265299 scopus 로고    scopus 로고
    • Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study
    • Jensen DM, Damm P, Moelsted-Pedersen L, et al.Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study.Diabet care 2004; 27(12): 2819-23
    • (2004) Diabet Care , vol.27 , Issue.12 , pp. 2819-2823
    • Jensen, D.M.1    Damm, P.2    Moelsted-Pedersen, L.3
  • 14
    • 0034886380 scopus 로고    scopus 로고
    • Clinical impact of mild carbohydrate intolerance in pregnancy: A study of 2904 nondiabetic danish women with risk factors for gestational diabetes mellitus
    • Jensen DM, Damm P, Sorensen B, et al.Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus.Am J Obstet Gynecol 2001; 185(2): 413-19
    • (2001) Am J Obstet Gynecol , vol.185 , Issue.2 , pp. 413-419
    • Jensen, D.M.1    Damm, P.2    Sorensen, B.3
  • 15
    • 37549019708 scopus 로고    scopus 로고
    • Adverse pregnancy outcome in women with mild glucose intolerance: Is there a clinically meaningful threshold value for glucose?
    • Jensen DM, Korsholm L, Ovesen P, et al.Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose?.Acta Obstet Gynecol Scand 2008; 87(1): 59-62
    • (2008) Acta Obstet Gynecol Scand , vol.87 , Issue.1 , pp. 59-62
    • Jensen, D.M.1    Korsholm, L.2    Ovesen, P.3
  • 16
    • 34247564947 scopus 로고    scopus 로고
    • Pregnancy plasma glucose levels exceeding the american diabetes association thresholds, but below the national diabetes data group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia
    • Ferrara A, Weiss NS, Hedderson MM, et al.Pregnancy plasma glucose levels exceeding the american diabetes association thresholds, but below the national diabetes data group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia.Diabetologia 2007; 50(2): 298-306
    • (2007) Diabetologia , vol.50 , Issue.2 , pp. 298-306
    • Ferrara, A.1    Weiss, N.S.2    Hedderson, M.M.3
  • 17
    • 0029084303 scopus 로고
    • Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes the toronto tri-hospital gestational diabetes project
    • Sermer M, Naylor CD, Gare DJ, et al.Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes.The toronto tri-hospital gestational diabetes project.Am J Obstet Gynecol 1995; 173(1): 146-56
    • (1995) Am J Obstet Gynecol , vol.173 , Issue.1 , pp. 146-156
    • Sermer, M.1    Naylor, C.D.2    Gare, D.J.3
  • 18
    • 84880257824 scopus 로고    scopus 로고
    • Benefits and harms of treating gestational diabetes mellitus: A systematic review and meta-Analysis for the us preventive services task force and the national institutes of health office of medical applications of research
    • Hartling L, Dryden DM, Guthrie A, et al.Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-Analysis for the U.S.preventive services task force and the national institutes of health office of medical applications of research.Ann Intern Med 2013; 159(2): 123-9
    • (2013) Ann Intern Med , vol.159 , Issue.2 , pp. 123-129
    • Hartling, L.1    Dryden, D.M.2    Guthrie, A.3
  • 19
    • 44649090496 scopus 로고    scopus 로고
    • Managing preexisting diabetes for pregnancy: Summary of evidence and consensus recommendations for care
    • Kitzmiller JL, Block JM, Brown FM, et al.Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.Diabet care 2008; 31(5): 1060-79
    • (2008) Diabet Care , vol.31 , Issue.5 , pp. 1060-1079
    • Kitzmiller, J.L.1    Block, J.M.2    Brown, F.M.3
  • 20
    • 0034687440 scopus 로고    scopus 로고
    • A comparison of glyburide and insulin in women with gestational diabetes mellitus
    • Langer O, Conway DL, Berkus MD, et al A comparison of glyburide and insulin in women with gestational diabetes mellitus.N Engl J Med 2000; 343(16): 1134-8
    • (2000) N Engl J Med , vol.343 , Issue.16 , pp. 1134-1138
    • Langer, O.1    Conway, D.L.2    Berkus, M.D.3
  • 21
    • 12844270104 scopus 로고    scopus 로고
    • Insulin and glyburide therapy: Dosage, severity level of gestational diabetes, and pregnancy outcome
    • Langer O, Yogev Y, Xenakis EM, et al.Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.Am J Obstet Gynecol 2005; 192(1): 134-9
    • (2005) Am J Obstet Gynecol , vol.192 , Issue.1 , pp. 134-139
    • Langer, O.1    Yogev, Y.2    Xenakis, E.M.3
  • 22
    • 84892456358 scopus 로고    scopus 로고
    • Anti-diabetic drug utilization of pregnant diabetic women in us managed care
    • Knox CA, Delaney JA, Winterstein AG.Anti-diabetic drug utilization of pregnant diabetic women in us managed care.BMC Pregnancy Childbirth 2014; 14: 28
    • (2014) BMC Pregnancy Childbirth , vol.14 , pp. 28
    • Knox, C.A.1    Delaney, J.A.2    Winterstein, A.G.3
  • 23
    • 2442678007 scopus 로고    scopus 로고
    • Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (nph insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes
    • Hermansen K, Fontaine P, Kukolja KK, et al.Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.Diabetologia 2004; 47(4): 622-9
    • (2004) Diabetologia , vol.47 , Issue.4 , pp. 622-629
    • Hermansen, K.1    Fontaine, P.2    Kukolja, K.K.3
  • 24
    • 0034537104 scopus 로고    scopus 로고
    • Insulin aspart vs.human insulin in the management of long-Term blood glucose control in type 1 diabetes mellitus: A randomized controlled trial
    • Home PD, Lindholm A, Riis A, et al.Insulin aspart vs.human insulin in the management of long-Term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.Diabet Med 2000; 17(11): 762-70
    • (2000) Diabet Med , vol.17 , Issue.11 , pp. 762-770
    • Home, P.D.1    Lindholm, A.2    Riis, A.3
  • 25
    • 0034827469 scopus 로고    scopus 로고
    • Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (hoe 901) and nph insulin
    • Rosenstock J, Schwartz SL, Clark CM Jr, et al.Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.Diabet care 2001; 24(4): 631-6
    • (2001) Diabet Care , vol.24 , Issue.4 , pp. 631-636
    • Rosenstock, J.1    Schwartz, S.L.2    Clark, C.M.3
  • 26
    • 20444394776 scopus 로고    scopus 로고
    • Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy
    • Wyatt JW, Frias JL, Hoyme HE, et al.Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy.Diabet Med 2005; 22(6): 803-7
    • (2005) Diabet Med , vol.22 , Issue.6 , pp. 803-807
    • Wyatt, J.W.1    Frias, J.L.2    Hoyme, H.E.3
  • 27
    • 39149086086 scopus 로고    scopus 로고
    • Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: An italian experience
    • Lapolla A, Dalfra MG, Spezia R, et al.Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience.Acta Diabetol 2008; 45(1): 61-6
    • (2008) Acta Diabetol , vol.45 , Issue.1 , pp. 61-66
    • Lapolla, A.1    Dalfra, M.G.2    Spezia, R.3
  • 28
    • 38549141135 scopus 로고    scopus 로고
    • Fetal and perinatal outcomes in type 1 diabetes pregnancy: A randomized study comparing insulin aspart with human insulin in 322 subjects
    • 186
    • Hod M, Damm P, Kaaja R, et al.Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.Am J Obstet Gynecol 2008; 198(2): 186 e1-7
    • (2008) Am J Obstet Gynecol , vol.198 , Issue.2 , pp. e1-e7
    • Hod, M.1    Damm, P.2    Kaaja, R.3
  • 29
    • 34147093269 scopus 로고    scopus 로고
    • Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women
    • Mathiesen ER, Kinsley B, Amiel SA, et al.Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.Diabet Care 2007; 30(4): 771-6
    • (2007) Diabet Care , vol.30 , Issue.4 , pp. 771-776
    • Mathiesen, E.R.1    Kinsley, B.2    Amiel, S.A.3
  • 30
    • 34147140029 scopus 로고    scopus 로고
    • Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: Comparison with regular insulin
    • Di Cianni G, Volpe L, Ghio A, et al.Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin.Diabet Care 2007; 30(4): e11
    • (2007) Diabet Care , vol.30 , Issue.4 , pp. e11
    • Di Cianni, G.1    Volpe, L.2    Ghio, A.3
  • 31
    • 0141889030 scopus 로고    scopus 로고
    • Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: Comparison with non-diabetic pregnant women
    • Mecacci F, Carignani L, Cioni R, et al.Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women.Eur J Obstet Gynecol Reprod Biol 2003; 111(1): 19-24
    • (2003) Eur J Obstet Gynecol Reprod Biol , vol.111 , Issue.1 , pp. 19-24
    • Mecacci, F.1    Carignani, L.2    Cioni, R.3
  • 32
    • 51549106264 scopus 로고    scopus 로고
    • Use of glargine in pregnant women with type 1 diabetes mellitus: A case-control study
    • Imbergamo MP, Amato MC, Sciortino G, et al.Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.Clin Ther 2008; 30(8): 1476-84
    • (2008) Clin Ther , vol.30 , Issue.8 , pp. 1476-1484
    • Imbergamo, M.P.1    Amato, M.C.2    Sciortino, G.3
  • 34
    • 33847784767 scopus 로고    scopus 로고
    • Use of insulin glargine during pregnancy: A case-control pilot study
    • Price N, Bartlett C, Gillmer M.Use of insulin glargine during pregnancy: a case-control pilot study.BJOG 2007; 114(4): 453-7
    • (2007) BJOG , vol.114 , Issue.4 , pp. 453-457
    • Price, N.1    Bartlett, C.2    Gillmer, M.3
  • 35
    • 84883743968 scopus 로고    scopus 로고
    • The use of insulin analogues in pregnancy
    • Lambert K, Holt RI.The use of insulin analogues in pregnancy.Diabetes Obes Metab 2013; 15(10): 888-900
    • (2013) Diabetes Obes Metab , vol.15 , Issue.10 , pp. 888-900
    • Lambert, K.1    Holt, R.I.2
  • 37
    • 84866653669 scopus 로고    scopus 로고
    • Maternal efficacy and safety outcomes in a randomized controlled trial comparing insulin detemir with nph insulin in 310 pregnant women with type 1 diabetes
    • Mathiesen ER, Hod M, Ivanisevic M, et al.Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes.Diabet Care 2012; 35(10): 2012-17
    • (2012) Diabet Care , vol.35 , Issue.10 , pp. 2012-2017
    • Mathiesen, E.R.1    Hod, M.2    Ivanisevic, M.3
  • 38
    • 0036313580 scopus 로고    scopus 로고
    • Albumin binding of acylated insulin (nn304) does not deter action to stimulate glucose uptake
    • Dea MK, Hamilton-Wessler M, Ader M, et al.Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake.Diabetes 2002; 51(3): 762-9
    • (2002) Diabetes , vol.51 , Issue.3 , pp. 762-769
    • Dea, M.K.1    Hamilton-Wessler, M.2    Ader, M.3
  • 39
    • 9044226136 scopus 로고    scopus 로고
    • Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs
    • Markussen J, Havelund S, Kurtzhals P, et al.Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs.Diabetologia 1996; 39(3): 281-8
    • (1996) Diabetologia , vol.39 , Issue.3 , pp. 281-288
    • Markussen, J.1    Havelund, S.2    Kurtzhals, P.3
  • 40
    • 77955824820 scopus 로고    scopus 로고
    • How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes
    • Arnolds S, Kuglin B, Kapitza C, et al.How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes.Int J Clin Pract 2010; 64(10): 1415-24
    • (2010) Int J Clin Pract , vol.64 , Issue.10 , pp. 1415-1424
    • Arnolds, S.1    Kuglin, B.2    Kapitza, C.3
  • 41
    • 0003852563 scopus 로고    scopus 로고
    • Time-Action profile of the soluble, fatty acid acylated, long-Acting insulin analogue nn304
    • Heinemann L, Sinha K, Weyer C, et al.Time-Action profile of the soluble, fatty acid acylated, long-Acting insulin analogue NN304.Diabet Med 1999; 16(4): 332-8
    • (1999) Diabet Med , vol.16 , Issue.4 , pp. 332-338
    • Heinemann, L.1    Sinha, K.2    Weyer, C.3
  • 42
    • 20944432717 scopus 로고    scopus 로고
    • A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-Acting insulin analog detemir
    • Plank J, Bodenlenz M, Sinner F, et al A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-Acting insulin analog detemir.Diabetes Care 2005; 28(5): 1107-12
    • (2005) Diabetes Care , vol.28 , Issue.5 , pp. 1107-1112
    • Plank, J.1    Bodenlenz, M.2    Sinner, F.3
  • 43
    • 33947644300 scopus 로고    scopus 로고
    • Albumin-bound basal insulin analogues (insulin detemir and nn344): Comparable time-Action profiles but less variability than insulin glargine in type 2 diabetes
    • Klein O, Lynge J, Endahl L, et al.Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-Action profiles but less variability than insulin glargine in type 2 diabetes.Diabetes Obes Metab 2007; 9(3): 290-9
    • (2007) Diabetes Obes Metab , vol.9 , Issue.3 , pp. 290-299
    • Klein, O.1    Lynge, J.2    Endahl, L.3
  • 44
    • 34547908855 scopus 로고    scopus 로고
    • Towards peakless, reproducible and long-Acting insulins an assessment of the basal analogues based on isoglycaemic clamp studies
    • Heise T, Pieber TR.Towards peakless, reproducible and long-Acting insulins.An assessment of the basal analogues based on isoglycaemic clamp studies.Diabetes Obes Metab 2007; 9(5): 648-59
    • (2007) Diabetes Obes Metab , vol.9 , Issue.5 , pp. 648-659
    • Heise, T.1    Pieber, T.R.2
  • 45
    • 2542576404 scopus 로고    scopus 로고
    • Lower within-subject variability of insulin detemir in comparison to nph insulin and insulin glargine in people with type 1 diabetes
    • Heise T, Nosek L, Ronn BB, et al.Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.Diabetes 2004; 53(6): 1614-20
    • (2004) Diabetes , vol.53 , Issue.6 , pp. 1614-1620
    • Heise, T.1    Nosek, L.2    Ronn, B.B.3
  • 46
    • 0342657181 scopus 로고    scopus 로고
    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
    • Kurtzhals P, Schaffer L, Sorensen A, et al.Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.Diabetes 2000; 49(6): 999-1005
    • (2000) Diabetes , vol.49 , Issue.6 , pp. 999-1005
    • Kurtzhals, P.1    Schaffer, L.2    Sorensen, A.3
  • 47
    • 33749485995 scopus 로고    scopus 로고
    • Novel insulin analogues and its mitogenic potential
    • Zib I, Raskin P.Novel insulin analogues and its mitogenic potential.Diabetes Obes Metab 2006; 8(6): 611-20
    • (2006) Diabetes Obes Metab , vol.8 , Issue.6 , pp. 611-620
    • Zib, I.1    Raskin, P.2
  • 48
    • 84864390304 scopus 로고    scopus 로고
    • Effect of insulin analogues on insulin/igf1 hybrid receptors: Increased activation by glargine but not by its metabolites m1 and m2
    • Pierre-Eugene C, Pagesy P, Nguyen TT, et al.Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2.PLoS ONE 2012; 7(7): e41992
    • (2012) PLoS ONE , vol.7 , Issue.7 , pp. e41992
    • Pierre-Eugene, C.1    Pagesy, P.2    Nguyen, T.T.3
  • 49
    • 84869780310 scopus 로고    scopus 로고
    • Plasma exposure to insulin glargine and its metabolites m1 and m2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes
    • Bolli GB, Hahn AD, Schmidt R, et al.Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes.Diabetes Care 2012; 35(12): 2626-30
    • (2012) Diabetes Care , vol.35 , Issue.12 , pp. 2626-2630
    • Bolli, G.B.1    Hahn, A.D.2    Schmidt, R.3
  • 50
    • 77955515434 scopus 로고    scopus 로고
    • Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling
    • Sciacca L, Cassarino MF, Genua M, et al.Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling.Diabetologia 2010; 53(8): 1743-53
    • (2010) Diabetologia , vol.53 , Issue.8 , pp. 1743-1753
    • Sciacca, L.1    Cassarino, M.F.2    Genua, M.3
  • 51
    • 78649633536 scopus 로고    scopus 로고
    • Insulin glargine is more potent in activating the human igf-i receptor than human insulin and insulin detemir
    • Varewijck AJ, Goudzwaard JA, Brugts MP, et al.Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.Growth Horm IGF Res 2010; 20(6): 427-31
    • (2010) Growth Horm IGF Res , vol.20 , Issue.6 , pp. 427-431
    • Varewijck, A.J.1    Goudzwaard, J.A.2    Brugts, M.P.3
  • 52
    • 77149157235 scopus 로고    scopus 로고
    • Oral hypoglycemic therapy: Understanding the mechanisms of transplacental transfer
    • Pollex EK, Feig DS, Koren G.Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer.J Matern Fetal Neonatal Med 2010; 23(3): 224-8
    • (2010) J Matern Fetal Neonatal Med , vol.23 , Issue.3 , pp. 224-228
    • Pollex, E.K.1    Feig, D.S.2    Koren, G.3
  • 53
    • 0025369820 scopus 로고
    • Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus.its role in fetal macrosomia
    • Menon RK, Cohen RM, Sperling MA, et al.Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus.Its role in fetal macrosomia.N Engl J Med 1990; 323(5): 309-15
    • (1990) N Engl J Med , vol.323 , Issue.5 , pp. 309-315
    • Menon, R.K.1    Cohen, R.M.2    Sperling, M.A.3
  • 54
    • 0027480433 scopus 로고
    • Insulin use in pregnancy clinical pharmacokinetic considerations
    • Crombach G, Siebolds M, Mies R.Insulin use in pregnancy.Clinical pharmacokinetic considerations.Clin Pharmacokinet 1993; 24(2): 89-100
    • (1993) Clin Pharmacokinet , vol.24 , Issue.2 , pp. 89-100
    • Crombach, G.1    Siebolds, M.2    Mies, R.3
  • 55
    • 84870042099 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus
    • Morello CM.Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus.Int J Gen Med 2011; 4: 827-35
    • (2011) Int J Gen Med , vol.4 , pp. 827-835
    • Morello, C.M.1
  • 57
    • 84856762404 scopus 로고    scopus 로고
    • Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy
    • Murphy HR, Elleri D, Allen JM, et al.Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.Diabetologia 2012; 55(2): 282-93
    • (2012) Diabetologia , vol.55 , Issue.2 , pp. 282-293
    • Murphy, H.R.1    Elleri, D.2    Allen, J.M.3
  • 58
    • 84889651836 scopus 로고    scopus 로고
    • A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine hagedorn in type 1 diabetes
    • Hod M, Mathiesen ER, Jovanovic L, et al A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes.J Matern Fetal Neonatal Med 2014; 27(1): 7-13
    • (2014) J Matern Fetal Neonatal Med , vol.27 , Issue.1 , pp. 7-13
    • Hod, M.1    Mathiesen, E.R.2    Jovanovic, L.3
  • 59
    • 0028881574 scopus 로고
    • Hypoglycemia: The price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus
    • Rosenn BM, Miodovnik M, Holcberg G, et al.Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus.Obstet Gynecol 1995; 85(3): 417-22
    • (1995) Obstet Gynecol , vol.85 , Issue.3 , pp. 417-422
    • Rosenn, B.M.1    Miodovnik, M.2    Holcberg, G.3
  • 60
    • 0030005968 scopus 로고    scopus 로고
    • Pregnancy outcomes in the diabetes control and complications trial
    • Pregnancy outcomes in the diabetes control and complications trial.Am J Obstet Gynecol 1996; 174(4): 1343-53
    • (1996) Am J Obstet Gynecol , vol.174 , Issue.4 , pp. 1343-1353
  • 61
    • 38148999538 scopus 로고    scopus 로고
    • Hypoglycemia in pregnant women with type 1 diabetes: Predictors and role of metabolic control
    • Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, et al.Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control.Diabetes Care 2008; 31(1): 9-14
    • (2008) Diabetes Care , vol.31 , Issue.1 , pp. 9-14
    • Nielsen, L.R.1    Pedersen-Bjergaard, U.2    Thorsteinsson, B.3
  • 62
    • 0036517101 scopus 로고    scopus 로고
    • Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy
    • Evers IM, ter Braak EW, de Valk HW, et al.Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.Diabetes Care 2002; 25(3): 554-9
    • (2002) Diabetes Care , vol.25 , Issue.3 , pp. 554-559
    • Evers, I.M.1    Ter Braak, E.W.2    De Valk, H.W.3
  • 63
    • 84879450961 scopus 로고    scopus 로고
    • The effect of real-Time continuous glucose monitoring in pregnant women with diabetes: A randomized controlled trial
    • Secher AL, Ringholm L, Andersen HU, et al.The effect of real-Time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.Diabetes Care 2013; 36(7): 1877-83
    • (2013) Diabetes Care , vol.36 , Issue.7 , pp. 1877-1883
    • Secher, A.L.1    Ringholm, L.2    Andersen, H.U.3
  • 64
    • 84888439373 scopus 로고    scopus 로고
    • Severe hypoglycemia in pregnant women with type 2 diabetes-A relevant clinical problem
    • Secher AL, Mathiesen ER, Andersen HU, et al.Severe hypoglycemia in pregnant women with type 2 diabetes-A relevant clinical problem.Diabetes Res Clin Pract 2013; 102(2): e17-18
    • (2013) Diabetes Res Clin Pract , vol.102 , Issue.2 , pp. e17-e18
    • Secher, A.L.1    Mathiesen, E.R.2    Andersen, H.U.3
  • 65
    • 84924952188 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion (csii) versus multiple daily injections (mdi) of rapid-Acting insulin analogues and detemir in type 1 diabetic (t1d) pregnant women
    • Mello G, Biagioni S, Ottanelli S, et al.Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-Acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.J Matern Fetal Neonatal Med 2014; 1-6
    • (2014) J Matern Fetal Neonatal Med , pp. 1-6
    • Mello, G.1    Biagioni, S.2    Ottanelli, S.3
  • 66
    • 84875389476 scopus 로고    scopus 로고
    • Treatment with the long-Acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: Comparison of glycaemic control and pregnancy outcome
    • Callesen NF, Damm J, Mathiesen JM, et al.Treatment with the long-Acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome.J Matern Fetal Neonatal Med 2013; 26(6): 588-92
    • (2013) J Matern Fetal Neonatal Med , vol.26 , Issue.6 , pp. 588-592
    • Callesen, N.F.1    Damm, J.2    Mathiesen, J.M.3
  • 67
    • 70350774087 scopus 로고    scopus 로고
    • Use of insulin detemir in pregnancy: A report on 10 type 1 diabetic women
    • Lapolla A, Di Cianni G, Bruttomesso D, et al.Use of insulin detemir in pregnancy: a report on 10 type 1 diabetic women.Diabet Med 2009; 26(11): 1181-2
    • (2009) Diabet Med , vol.26 , Issue.11 , pp. 1181-1182
    • Lapolla, A.1    Di Cianni, G.2    Bruttomesso, D.3
  • 68
    • 84862682811 scopus 로고    scopus 로고
    • Audit of insulin detemir in pregnancy: A retrospective case series
    • Shenoy VV, Cook SJ, Parry AF, et al.Audit of insulin detemir in pregnancy: a retrospective case series.Diabet Med 2012; 29(7): 958-9
    • (2012) Diabet Med , vol.29 , Issue.7 , pp. 958-959
    • Shenoy, V.V.1    Cook, S.J.2    Parry, A.F.3
  • 70
    • 84903792623 scopus 로고    scopus 로고
    • Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (hypoana trial): A prospective randomised open-label blinded-endpoint crossover trial
    • Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, et al.Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.Lancet Diabetes Endocrinol 2014; 2(7): 553-61
    • (2014) Lancet Diabetes Endocrinol , vol.2 , Issue.7 , pp. 553-561
    • Pedersen-Bjergaard, U.1    Kristensen, P.L.2    Beck-Nielsen, H.3
  • 71
    • 84888436978 scopus 로고    scopus 로고
    • Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: A finnish register linkage study
    • Haukka J, Hoti F, Erasto P, et al.Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study.Pharmacoepidemiol Drug Saf 2013; 22(12): 1326-35
    • (2013) Pharmacoepidemiol Drug Saf , vol.22 , Issue.12 , pp. 1326-1335
    • Haukka, J.1    Hoti, F.2    Erasto, P.3
  • 72
    • 84907169844 scopus 로고    scopus 로고
    • Proportion of gestational diabetes mellitus attributable to overweight and obesity among non-hispanic black, non-hispanic white, and hispanic women in south carolina
    • Cavicchia PP, Liu J, Adams SA, et al.Proportion of gestational diabetes mellitus attributable to overweight and obesity among non-hispanic black, non-hispanic white, and hispanic women in South Carolina.Matern Child Health J 2014; 18(8): 1919-26
    • (2014) Matern Child Health J , vol.18 , Issue.8 , pp. 1919-1926
    • Cavicchia, P.P.1    Liu, J.2    Adams, S.A.3
  • 73
    • 12744274870 scopus 로고    scopus 로고
    • Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to nph insulin in patients with type 2 diabetes
    • Haak T, Tiengo A, Draeger E, et al.Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.Diabetes Obes Metab 2005; 7(1): 56-64
    • (2005) Diabetes Obes Metab , vol.7 , Issue.1 , pp. 56-64
    • Haak, T.1    Tiengo, A.2    Draeger, E.3
  • 74
    • 84884742947 scopus 로고    scopus 로고
    • Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: Results from an observational study
    • Yale JF, Damci T, Kaiser M, et al.Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study.Diabetol Metab Syndr 2013; 5(1): 56
    • (2013) Diabetol Metab Syndr , vol.5 , Issue.1 , pp. 56
    • Yale, J.F.1    Damci, T.2    Kaiser, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.